SCHEMBL10129031

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL10129027	0.89	EML4 (0.65)	EML4ALKCAMK1DPRKCQ
	SCHEMBL10129012	0.86	EML4 (0.69)	EML4ALKCAMK1DPDE5A
	SCHEMBL10129013	0.86	EML4 (0.69)	EML4ALKCAMK1DPDE5A
	SCHEMBL10129032	0.85	EML4 (0.66)	EML4ALKCAMK1DPRKCQ
	SCHEMBL10129043	0.85	EML4 (0.66)	EML4ALKCAMK1DPRKCQ
	SCHEMBL10129054	0.83	EML4 (0.66)	EML4ALKCAMK1DPRKCQ
	SCHEMBL10129102	0.83	EML4 (0.65)	EML4ALKCAMK1DPDE5A
	SCHEMBL10129039	0.82	EML4 (0.62)	EML4ALKCAMK1DPRKCQ
	SCHEMBL10128988	0.81	EML4 (0.71)	EML4ALK
	SCHEMBL10129063	0.81	ALK (0.71)	EML4ALKCAMK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.